<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Bielefeld-CeBiTec_Results_Selection_Cloning skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Bielefeld-CeBiTec/Results/Selection/Cloning</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container main"><DIV id="header"><NAV id="navigationbar" class="navbar navbar-default custom_navbar_style navbar-fixed-top"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON><A class="navbar-brand" href="#">NavBar</A></DIV><DIV id="navbar" class="navbar-collapse collapse"><UL class="nav navbar-nav navbar-center"><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Description"> PROJECT </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Description">Description</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Library">Library</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Library">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Library/Scaffolds">Scaffolds</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Library/Design">Design and Construction</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Library/CreateYours">Create your own Library</A></LI></UL><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Mutation">Mutation</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Mutation">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Mutation/EpPolI">Error prone PolymeraseI</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Mutation/Global">Genome wide mutator</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Motivation">Selection</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Motivation">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System">Bacterial Two-Hybrid System</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/SplitBetaLactamaseHitchHiker">Alternative Selection System</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Model">Modeling</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Model">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Modeling/Model_I">Model I</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Modeling/Model_II">Model II</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results"> RESULTS </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results">Overview</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Library/Overview">Library</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Library/Overview">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Library/Assembly">Assembly</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Library/Phage">Phagemid Display</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Library/Sequencing">Sequencing</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Mutation">Mutation</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Mutation">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Mutation/Assembly">Assembly</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Mutation/Reversion">Reversion</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Mutation/Sequencing">Sequencing</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection">Selection</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/Cloning">Assembly</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/ExpressionControl">Expression Control</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/InteractionControl">Interaction Control</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/BindingControl">Binding Control</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/KnockOutKnochIn"><I>in vivo</I> Selection</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Modeling">Modeling</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Fermentation">Fermentation</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Basic_Part">Best Basic Part</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Composite_Part">Best Composite Part</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Part_Collection">Best Part Collection</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Parts/Improve">Improve a part</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Proof">Proof of Concept</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Demonstrate">Demonstrate your Work</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Medal_Fulfillment">Medal Fulfillment</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Gold"> HUMAN PRACTICES </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Gold">Overview</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Dictionary">Dictionary</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/School_Talks">Educational Outreach</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Crowdfunding">Crowdfunding and Press</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Silver">Achievements</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Collaborations"> COLLABORATIONS </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Collaborations">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Collaborations/Duesseldorf">DÃ¼sseldorf</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Collaborations/Lethbridge">Lethbridge</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Collaborations/Freiburg">Freiburg</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Experiments"> NOTEBOOK </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Experiments">Overview</A></LI><LI class="navbar_button dropdown dropdown-submenu"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Notebook">Lab Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Notebook/Library">Library</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Notebook/Mutation">Mutation</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Notebook/Selection">Selection</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Experiments/Primers">Primers</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Experiments/Protocols">Lab Protocols</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Experiments/Media">Media and Buffers</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Team"> TEAM </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Team">Team Profile</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Team/Members">Members</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Team/Bielefeld_University">Bielefeld University</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Team/Contact">Contact</A></LI><LI class="navbar_button dropdown"><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Acknowledgement"> ACKNOWLEDGEMENT </A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Acknowledgement">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Sponsors_And_Partners">Sponsors and Partners</A></LI><LI><A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Attributions">Attributions</A></LI></DIV></DIV></NAV></DIV></DIV><DIV class="container main"><DIV class="container text_header"><H1>Assembly</H1></DIV><DIV class="container text">
			For the construction of our BioBricks we did a lot of literature research to identify optimal templates for the selection system. Finally we decided to build a two-hybrid
			transcriptional activation system based on the cooperation of the repressor protein cI from one of two different phages with the omega subunit of the DNA-mediated 
			RNA polymerase of <I>Escherichia coli</I>. These two proteins were encoded on seperate plasmid backbones with different antibiotic resistances. For the first construction of 
			our system the backbones <A href="http://parts.igem.org/Part:pSB1C3">pSB1C3</A> and <A href="http://parts.igem.org/Part:pSB1K3">pSB1K3</A> were used. Our target was the 
			construction of fusion proteins, which contained on the one hand the cI protein fused with our target protein encoded on the pSB1K3 plasmid (<A href="http://parts.igem.org/Part:BBa_K2082225">BBa_K2082225</A>, part in pSB1C3) and on the other hand the RpoZ protein fused
			with our <B>Evobody</B> encoded on the pSB1C3 plasmid (<A href="http://parts.igem.org/Part:BBa_K2082221">BBa_K2082221</A>). The concept of the construction is illustrated in the figure (X). As positive control the domain SH2 of the tyrosine kinase Abl1
			as target and the monobody HA4 as binding protein are used. Also, the HA4 mutations Y87A (<A href="http://parts.igem.org/Part:BBa_K2082222">BBa_K2082222</A>), R38A(<A href="http://parts.igem.org/Part:BBa_K2082223">BBa_K2082223</A>) and the double mutation 
			R38A and E52A (<A href="http://parts.igem.org/Part:BBa_K2082224">BBa_K2082224</A>) were created. A detailed explanation about our decision for this 
			<A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Project/Selection/Bacterial_Two-Hybrid_System#Controls">bacterial two-hybrid system</A> is availble in our project description.
			
			In consideration of the space between both halves of our RpoZ-HA4 construct we designed a 30 base-pairs linker with an anti-cMyc binding site for easy detection of the expression of 
			the protein within the <I>E. coli</I> coli via <A href="#WesternBlot">western blot assay</A> with a cMyc antibody. For the cI-SH2 fusion protein we designed constructs with the alternative linkers
			possibilities. The BioBricks are designed without a linker (<A href="http://parts.igem.org/Part:BBa_K2082205">BBa_K2082205</A>), with a short nine base-pair linker 
			(<A href="http://parts.igem.org/Part:BBa_K2082206">BBa_K2082206</A>) and the cMyc-linker for integrated expression control (<A href="http://parts.igem.org/Part:BBa_K2082207">
			BBa_K2082207</A>). 
			
			The reporter of our system is based on a <I>lacZ</I> promoter expanded by the OR1 binding site for the cI repressor protein of the phage 434. To make the first studies of the transcriptional 
			activation we choose a RFP gene as the reporter (<A href="http://parts.igem.org/Part:BBa_K2082211">BBa_K2082211</A>). Stronger interaction should result in higher expression of RFP and a stronger red fluorescence in the <I>E. coli</I> cell. Later for 
			our final system the RFP is replaced by a beta-lactamase gene to put on a selection pressure on our bacteria(<A href="http://parts.igem.org/Part:BBa_K2082238">BBa_K2082238</A>). To use the reporter in our two plasmid system, the whole part was at first
			integrated upstream of the SH2-cI fusion protein encoding sequence(<A href="http://parts.igem.org/Part:BBa_K2082231">BBa_K2082231</A>).  
			
			The reporter activity could be dependent on the plasmid number. Therefore, a knock-in 
			of the reporter in the genome of our final <I>E. coli</I> strain JS200 with the <A href="#CRISPR">CRISPR/Cas9</A> system was done. The main construct of the knock-out was also added to the part registry (<A href="http://parts.igem.org/Part:BBa_K2082251">BBa_K2082251</A>)
			
			For different tests with our bacterial two-hybrid system more constructs were created. At first the DNA binding domain and the associated OR1 binding site was changed from the cI of the phage
			434 to the cI protein of the phage lambda(<A href="http://parts.igem.org/Part:BBa_K2082252">BBa_K2082252</A>). For the cI lambda sequence the part <A href="http://parts.igem.org/Part:BBa_K105004">BBa_K105004</A> and for the OR1 binding sequence the part <A href="http://parts.igem.org/Part:BBa_K105021">
			BBa_K105021</A> were used, respectivly. Another created part was an addition of the OR2 binding site (Hartmann et al. 2003) to our construct <A href="http://parts.igem.org/Part:BBa_K2082239">BBa_K2082239</A> to analyze if two binding sites 
			would make the binding strength of our DNA binding domain better. 
			
			The project development was supported by several <A href="https://2016.igem.org/Team:Bielefeld-CeBiTec/HP/Experts">experts</A>, who had many interesting advices for our system. One of the ideas was a change of our 
			resistance gene from beta-lactamase to the more commonly used antibiotic tetracycline. Therefore, we designed a part, which contains a reporter with a tetracycline resistance gene <I>tetA</I> cloned upstream of the RFP gene(<A href="http://parts.igem.org/Part:BBa_K2082237">BBa_K2082237</A>).
			This created a possibility to make a quantitative and qualitative analysis of the functionality of the bacterial two-hybrid system. 

		</DIV><CENTER><BUTTON><A class="button_link" href="https://2016.igem.org/Team:Bielefeld-CeBiTec/Results/Selection/ExpressionControl" role="button">Expression Control</A></BUTTON></CENTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>